Triterpenoid Antifungals

Name
Triterpenoid Antifungals
Accession Number
DBCAT005690
Description

Not Available

Drugs
DrugDrug Description
IbrexafungerpA triterpene antifungal indicated in the treatment of vulvovaginal candidiasis and prevention of recurrent vulvovaginal candidiasis in post-menarchal patients.
Drugs & Drug Targets
DrugTargetType
IbrexafungerpCytochrome P450 3A4enzyme
IbrexafungerpUDP-glucuronosyltransferases (UGTs)enzyme
IbrexafungerpSulfotransferaseenzyme
IbrexafungerpCytochrome P450 2C8enzyme
IbrexafungerpP-glycoprotein 1transporter
IbrexafungerpSolute carrier organic anion transporter family member 1B3transporter
IbrexafungerpSerum albumincarrier
Ibrexafungerp1,3-beta-glucan synthase component GSC2target
IbrexafungerpGTP-binding protein RHO1target